Activity

Hi Viera, Thanks for reaching out to connect! I have actually been trying to get in touch with the Bruker team as well so this is great timing. I would love to connect and explore opportunities for mutual collaboration. I am not certain our products are a great fit for this specific application, but it doesn’t hurt to have a quick get to know you call and see what comes of it. You can book a time convenient to you here, or let me know some availability windows and I can send out an invite. I look forward to chatting with you. Regards, Andrew Hartmann Business Development Manager – 25020 Avenue Tibbitts Valencia, CA 91355 – D +1.661.567.0667 P +1.888.UTAK.LAB F +1.661.294.9272 – Book a Meeting with Me https://calendly.com/ahartmann-utak/30min utak.com From: Crosignani, Viera <Viera.Crosignani@bruker.com> Sent: Monday, September 22, 2025 1:09 PM To: Andrew Hartmann <ahartmann@utak.com> Subject: Greetings from Bruker Spatial Biology (former NanoString) Dear Mr. Hartmann, My name is Viera and I am the spatial account manager for the Greater LA area at Bruker Spatial Biology (former NanoString). I am reaching out to explore a potential area of synergy between UTAK’s expertise in high-quality control materials and Bruker’s leadership in spatial biology technologies. As you know, spatial biology is rapidly transforming how researchers and clinicians study complex tissue microenvironments, enabling new insights in oncology, immunology, neuroscience, and beyond. With these advances comes an increasing need for robust, standardized quality controls that ensure data reliability, reproducibility, and confidence across laboratories. This is where UTAK’s strengths could be highly complementary. Bruker’s platforms—such as our advanced spatial multi-omics imaging systems—would greatly benefit from QC partners who can help us and our customers establish the highest standards in assay validation and inter-lab consistency. I would love to schedule a short call to discuss where our organizations might collaborate—whether in developing new QC solutions for emerging spatial biology assays, or in supporting labs that are bringing advanced tissue analysis into clinical and translational research. Would you be open to a conversation in the coming weeks? I believe there is strong potential to create value together at the intersection of quality control and next-generation spatial biology. Looking forward to your thoughts. Thank you for your time, have a wonderful day! Viera